
Sign up to save your podcasts
Or


Discussion of new data from the ADAGIO trial for the treatment of Parkinson's disease, and a Canadian cohort study assessing risk factors for multiple sclerosis in children.
By The Lancet NeurologyDiscussion of new data from the ADAGIO trial for the treatment of Parkinson's disease, and a Canadian cohort study assessing risk factors for multiple sclerosis in children.

43,588 Listeners

293 Listeners

518 Listeners

50 Listeners

112,194 Listeners

93 Listeners

512 Listeners

190 Listeners

61 Listeners

83 Listeners

0 Listeners